Connection

Wei Wang to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Wei Wang has written about Antibodies, Viral.
Wei Wang
Connection Strength
0.067
Antibodies, Viral
  1. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
    View in: PubMed
    Score: 0.021
  2. Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis. Ann Neurol. 2018 09; 84(3):386-400.
    View in: PubMed
    Score: 0.019
  3. Serologic and viral genome prevalence of HSV, EBV, and HCMV among healthy adults in Wuhan, China. J Med Virol. 2018 03; 90(3):571-581.
    View in: PubMed
    Score: 0.018
  4. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 06 13; 395(10240):1845-1854.
    View in: PubMed
    Score: 0.005
  5. Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses. J Infect Dis. 2017 Apr 01; 215(7):1107-1110.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.